Tevogen Bio Holdings Inc. (TVGN)
NGM · Common · CUSIP 88165K101
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for TVGN and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
88165K101
IPO
11/4/2021 · $10.00/unit
Previous Symbol
LGST (changed 3/21/2024)
Previous Name
Semper Paratus Acquisition Corp
Business: Tevogen Bio Holdings Inc. is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T lymphocytes, to develop off-the-shelf, genetically unmodified precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders, aiming to address the significant unmet needs of large patient populations.
Notes: Unit consists of one Class A ordinary share and one-third of one redeemable warrant.

Company Contact

CEO
Ryan Saadi
CFO
Kirti Desai
Headquarters
15 Independence Boulevard, Suite #410, Warren, NJ 07059
Phone
877-838-6434 · Toll-Free 877-838-6436
Investor Relations
877-838-6436 · communications@Tevogen.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »